Cleared Special

K240404 - NovaBone Putty - Bioactive Synthetic Bo...

K240404 is the FDA 510(k) clearance for NovaBone Putty - Bioactive Synthetic Bo... by Novabone Products, LLC. It is a Class 2 Orthopedic device (product code MQV) cleared through the Special 510(k) pathway after a 25-day FDA review.

K240404 · Novabone Products, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
25d
Days
Class 2
Risk

K240404 is an FDA 510(k) clearance for the NovaBone Putty - Bioactive Synthetic Bone Graft (NB6600, NB6610, NB6615). Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Novabone Products, LLC (Alachua, US). The FDA issued a Cleared decision on March 5, 2024 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Novabone Products, LLC devices

Submission Details

510(k) Number K240404 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 09, 2024
Decision Date March 05, 2024
Days to Decision 25 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 122d · This submission: 25d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Geyser Medical Consulting
David Gaisser

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 249
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K240404.
NuVasive AttraX Scaffold
K240507 · Nuvasive, Inc. · Mar 2024
Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix
K240424 · Collagen Matrix, Inc. · Mar 2024
Synthetic Bone Putty
K240458 · Ventris Medical · Mar 2024
Cerament Bone Void Filler
K240459 · Bonesupport AB · Mar 2024
ReBOSSIS
K240453 · Orthorebirth Co., Ltd. · Mar 2024
Mg OSTEOINJECT™
K234013 · Bone Solutions, Inc. · Feb 2024